DKP
IQMDW

Davidson Kempner Partners’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Davidson Kempner Partners’s Portfolio IQMDW Stock Details IQMDW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$2.3K Buy
+50,000
New +$2.15K ﹤0.01% 362

Other funds holding IQMDW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Davidson Kempner Partners's IQMDW Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q1 2023: 50,000 shares worth $2.3K. The stake represents ﹤0.01% of the portfolio and ranks #362 among its holdings.

49 funds tracked by Wall St. Rank hold IQMDW as of Q1 2023.

  • Davidson Kempner Partners held 50,000 shares of Intelligent Medicine Acquisition Corp. Warrant worth $2.3K as of Q1 2023.
  • Intelligent Medicine Acquisition Corp. Warrant was a new Davidson Kempner Partners position in Q1 2023.
  • Intelligent Medicine Acquisition Corp. Warrant made up ﹤0.01% of Davidson Kempner Partners's portfolio in Q1 2023, its #362 holding.
  • 49 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.